Effect of Cross-Linking on the Performance of Micelles As Drug Delivery Carriers: A Cell Uptake Study
- 27 February 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 13 (3), 814-825
- https://doi.org/10.1021/bm201730p
Abstract
Poly(polyethylene glycol methyl ether methacrylate-co-methacrylic acid)-block-poly(methyl methacrylate) P(PEGMEMA-co-MAA)-b-PMMA block copolymer were prepared via RAFT (reversible addition-fragmentation chain transfer) polymerization and subsequently self-assembled into micelles as a drug delivery carrier for albendazole (ABZ). For comparison, the micelles were additionally cross-linked to study the effect of shell-cross-linking on the biological activity. The hydrodynamic diameter of cross-linked and un-cross-linked micelles was approximately 40 nm in both cases. While the cross-linked micelle was stable even in good solvents for both blocks, the un-cross-linked micelle was found to lose its integrity in cell growth media. Crosslinking had a major effect on the rate of drug release reducing it dramatically from 50% (uncrosslinked) to around 20% (crosslinked) over a 30 h incubation period. Both drug delivery systems were tested on human prostate cancer cells (PC-3, DU-145) and human ovarian cancer cells (OVCAR-3, A-2780). No toxic effects were measured with the unloaded micelle while the ABZ loaded un-cross-linked micelle lead to IC(50) values between 0.2 and 0.9 μM depending on the cell line. The IC(50) dropped to values between 0.006 and 0.06 μM, depending on cell line, once the micelles were stabilized by cross-linking. Three treatment cycles with ABZ for one day, followed by two days incubation in media using ABZ-loaded drug carriers led to complete cell death even at low concentrations in the case of the cross-linked micelle only. Cellular uptake has been studied using fluorescently labeled micelles and Nile red as model drug, showing cell uptake above the CMC but no micelle uptake below the CMC. Additional biological studies, such as colony formation assay and tubulin disorganization tests, were also performed to gain more insight into the effect of cross-linking of the shell of the micelle. In conclusion, shell-cross-linking is highly recommended, even for glassy micelles, for an efficient cellular uptake at low concentrations.Keywords
This publication has 55 references indexed in Scilit:
- Microtubule-binding agents: a dynamic field of cancer therapeuticsNature Reviews Drug Discovery, 2010
- Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesisBiochemical and Biophysical Research Communications, 2010
- Potent inhibition of tumoral hypoxia-inducible factor 1α by albendazoleBMC Cancer, 2010
- RAFT polymerization: an avenue to functional polymeric micelles for drug deliveryChemical Communications, 2008
- Albendazole: a Potent Inhibitor of Vascular Endothelial Growth Factor and Malignant Ascites Formation in OVCAR-3 Tumor-Bearing Nude MiceClinical Cancer Research, 2006
- Block copolymer micelles as delivery vehicles of hydrophobic drugs: Micelle–cell interactionsJournal of Drug Targeting, 2006
- Antitumor activity of albendazole against the human colorectal cancer cell line HT-29: in vitro and in a xenograft model of peritoneal carcinomatosisCancer Chemotherapy and Pharmacology, 2004
- In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazoleCancer Letters, 2001
- Interactions of benzimidazoles (BZ) with tubulin from BZ-sensitive and BZ-resistant isolates of Haemonchus contortusMolecular and Biochemical Parasitology, 1986
- Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal roundwormsCellular and Molecular Life Sciences, 1976